|
HY-115524-1mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-10mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-100mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-25mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-5mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-115524-50mg
|
MedChemexpress LLC
|
DBCO-NHS ester 2 [CAS 1384870-47-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-128915-10mg
|
MedChemexpress LLC
|
Duocarmycin DM (free base) [CAS 1116745-06-2]
|
|
Cancer-programmed cell death
|
|
|
HY-128915-100mg
|
MedChemexpress LLC
|
Duocarmycin DM (free base) [CAS 1116745-06-2]
|
|
Cancer-programmed cell death
|
|
|
HY-128915-25mg
|
MedChemexpress LLC
|
Duocarmycin DM (free base) [CAS 1116745-06-2]
|
|
Cancer-programmed cell death
|
|
|
HY-128915-5mg
|
MedChemexpress LLC
|
Duocarmycin DM (free base) [CAS 1116745-06-2]
|
|
Cancer-programmed cell death
|
|
|
HY-128915-50mg
|
MedChemexpress LLC
|
Duocarmycin DM (free base) [CAS 1116745-06-2]
|
|
Cancer-programmed cell death
|
|
|
HY-141898-10mg
|
MedChemexpress LLC
|
Biotin-4-aminophenol [CAS 901770-40-9]
|
|
|
|
|
HY-141898-100mg
|
MedChemexpress LLC
|
Biotin-4-aminophenol [CAS 901770-40-9]
|
|
|
|
|
HY-141898-25mg
|
MedChemexpress LLC
|
Biotin-4-aminophenol [CAS 901770-40-9]
|
|
|
|
|
HY-141898-5mg
|
MedChemexpress LLC
|
Biotin-4-aminophenol [CAS 901770-40-9]
|
|
|
|
|
HY-141898-50mg
|
MedChemexpress LLC
|
Biotin-4-aminophenol [CAS 901770-40-9]
|
|
|
|
|
HY-D0078-10mg
|
MedChemexpress LLC
|
DCIA [CAS 76877-34-4]
|
|
|
|
|
HY-P99110-1mg
|
MedChemexpress LLC
|
Lanadelumab [CAS 1426055-14-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99110-10mg
|
MedChemexpress LLC
|
Lanadelumab [CAS 1426055-14-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99110-5mg
|
MedChemexpress LLC
|
Lanadelumab [CAS 1426055-14-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99191-1mg
|
MedChemexpress LLC
|
Emapalumab [CAS 1709815-23-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99191-10mg
|
MedChemexpress LLC
|
Emapalumab [CAS 1709815-23-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99191-5mg
|
MedChemexpress LLC
|
Emapalumab [CAS 1709815-23-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-P9933-1mg
|
MedChemexpress LLC
|
Dinutuximab [CAS 1363687-32-4]
|
|
|
|
|
HY-P9933-10mg
|
MedChemexpress LLC
|
Dinutuximab [CAS 1363687-32-4]
|
|
|
|
